Novel Assay Using Total Hepatitis C Virus (HCV) Core Antigen quantification for Diagnosis of HCV Infection in Dialysis Patients

Dialysis patients remain a high-risk group for hepatitis C virus (HCV) infection. The current diagnosis of HCV infection among dialysis patients includes serological assays and nucleic acid amplification technology (NAT) for assessing serum anti-HCV antibody and HCV viremia, respectively. However, c...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Microbiol
Asıl Yazarlar: Fabrizi, Fabrizio, Lunghi, Giovanna, Aucella, Filippo, Mangano, Stefano, Barbisoni, Francesco, Bisegna, Sergio, Vigilante, Domenico, Limido, Aurelio, Martin, Paul
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology (ASM) 2005
Konular:
Virology
Online Erişim:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC540167/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15635003/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JCM.43.1.414-420.2005
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller